Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET) (NCT04032470)
Boston Scientific Registry of Deep Brain Stimulations for Treatment of Essential Tremor (ET):ET Registry
🩺 Plain-English Summary (8th-Grade Level)
To compile characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Deep Brain Stimulation (DBS) Systems, when used according to the applicable Directions for Use, for the treatment of Essential Tremor.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (2 items) and avoid the listed exclusions (2 items).
Location: A.o. LKH Univ.-Kliniken Innsbruck — Innsbruck
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Meets any contraindication in locally applicable Directions for Use
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (20 Sites)
- A.o. LKH Univ.-Kliniken Innsbruck — Innsbruck,
- AZ Sint-Lucas — Ghent,
- UZ Gasthuisberg — Leuven,
- AZ Delta — Roeselare,
- Vancouver General Hospital — Vancouver,
- Uniklinik Koln — Cologne,
- Universitaetsklinikum Dusseldorf — Düsseldorf,
- Universitaetsklinikum Essen — Essen,
- Universitatsklinikum Campus Kiel — Kiel,
- Universitaetsklinikum Giessen und Marburg GmbH — Marburg,
- Evangelisches Krankenhaus Oldenburg — Oldenburg,
- Universitaetsklinikum Wuerzburg — Würzburg,
- Medical School of University PECS — Pécs,
- Policlinico Universitario Agostino Gemelli — Rome,
- CHU Sao Joao — Porto,
- Samsung Medical Center — Seoul,
- Seoul ASAN Medical Center — Seoul,
- Yonsei University Severance Hospital — Seoul,
- Hospital De Bellvitge — Barcelona,
- Hospital General De Asturias — Oviedo,
📞 Contact the Study Coordinator
Phone: (855) 213-9890
Email: BSNClinicalTrials@bsci.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Essential Tremor
- Long-Term Transcutaneous Stimulation and Essential Tremor: A PET Study — Rochester, Minnesota
- Bilateral Treatment of Medication Refractory Essential Tremor — Stanford, California
- GyroGlove Use in Essential Tremor Patients — Farmington Hills, Michigan
- Ultrasound Neuromodulation in Essential Tremor — San Francisco, California
- Attention and Eye Movement in Parkinson's Disease — Omaha, Nebraska
- Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET) — Morgantown, West Virginia
Explore by condition: All Essential Tremor clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.